Clinical Trial Update: NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy

View source ↗

Summary

A completed clinical study evaluating signatures of Tumor Treating Fields therapy (NovoTTF-100A System) in glioblastoma patients, with autopsy analyses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• NovoTTF-100A System (Tumor Treating Fields (TTFields) therapy)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Glioblastoma | Status: COMPLETED